RT Journal Article
SR Electronic
T1 Changing patterns of SARS-CoV-2 infection through Delta and Omicron waves by vaccination status, previous infection and neighbourhood deprivation: A cohort analysis of 2.7M people
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.04.05.22273169
DO 10.1101/2022.04.05.22273169
A1 Mark A. Green
A1 Daniel J. Hungerford
A1 David M. Hughes
A1 Marta Garcia-Fiñana
A1 Lance Turtle
A1 Christopher Cheyne
A1 Matthew Ashton
A1 Gary Leeming
A1 Malcolm G. Semple
A1 Alex Singleton
A1 Iain Buchan
YR 2022
UL http://medrxiv.org/content/early/2022/04/21/2022.04.05.22273169.abstract
AB Objective To examine if SARS-CoV-2 infections vary by vaccination status, if an individual had previously tested positive and by neighbourhood socioeconomic deprivation across the Delta and Omicron epidemic waves of SARS-CoV-2.Design Cohort study using electronic health recordsSetting Cheshire and Merseyside, England (3rd June 2021 to 1st March 2022)Participants 2.7M residentsMain Outcome measure Registered positive test for SARS-CoV-2Results Social inequalities in registered positive tests were dynamic during the study. Originally higher SARS-CoV-2 rates in the most socioeconomically deprived neighbourhoods changed to being higher in the least deprived neighbourhoods from the 1st September 2021. While the introduction of Omicron initially reset inequalities, they continued to be dynamic and inconsistent. Individuals who were fully vaccinated (two doses) were associated with fewer registered positive tests (e.g., between 1st September and 27th November 2021: (i) individuals engaged in testing – Hazards Ratio (HR) = 0.48, 95% Confidence Intervals (CIs) = 0.47-0.50; (ii) individuals engaged with healthcare - HR = 0.34, 95% CIs = 0.33-0.34). Individuals with a previous registered positive test were also less likely to have a registered positive test (e.g., between 1st September and 27th November 2021: (i) individuals engaged in testing - HR = 0.16, 95% CIs = 0.15-0.18; (ii) individuals engaged with healthcare - HR = 0.14, 95% CIs = 0.13-0.16). However, Omicron is disrupting these associations due to immune escape resulting in smaller effect sizes for both measures.Conclusions Changing patterns of SARS-CoV-2 infections during the Delta and Omicron waves reveals a dynamic pandemic that continues to affect diverse communities in sometimes unexpected ways.Competing Interest StatementIB declares grants from NIHR, personal fees and other from AstraZeneca, outside the submitted work. MGS declares non-remunerated participation on Pfizers External Data Monitoring Committee for their mRNA vaccine programmes. MGS holds stocks in Integrum Scientific LLC and MedEx Solutions Ltd. MGS also declares being a non-remunerated independent member of the UK Governments SAGE and NERVTAG groups. No further conflicts of interest are declared.Funding StatementThis work was supported by the Medical Research Council [grant number MR/W021242/1], the Department of Health and Social Care (DHSC), the National Institute for Health Research (NIHR) Health Protection Research Unit (HPRU) in Gastrointestinal Infections, a partnership between UK Health Security Agency (UKHSA), the University of Liverpool and the University of Warwick [Grant No: NIHR ref NIHR200910] and the NIHR HPRU in Emerging and Zoonotic Infections, a partnership between UKHSA, the University of Liverpool in collaboration with the Liverpool School of Tropical Medicine and the University of Oxford [Grant No: NIHR ref NIHR200907]. The views expressed are those of the authors and not necessarily those of the NIHR, UKHSA or DHSC. The funding sources had no roles in the design of the study or the decision to submit the paper for publication.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethical approval was granted by the University of Liverpools Research Ethics committee (REF: 10634).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData are accessible via CIPHA (https://www.cipha.nhs.uk/). Requests can be made to the Data Access Committee for extracts of the larger-scale data which cannot be released openly due to information governance requirements. All analyses were undertaking using open source R statistical software and code is made openly available here https://github.com/markagreen/social_flip_COVID-19. https://github.com/markagreen/social_flip_COVID-19